4-[2-[[(Z)-pent-2-enyl]disulfanyl]ethyl]morpholine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-[2-[[(Z)-pent-2-enyl]disulfanyl]ethyl]morpholine
• 化学式: C₁₁H₂₁NOS₂
• 分子量: 247.4
• InChiKey: SKPZTOKAKCHHIY-ARJAWSKDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  63.1
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• CHIRAL CONTROL
  申请人：WAVE LIFE SCIENCES PTE. LTD.

  公开号：US20150211006A1

  公开（公告）日：2015-07-30

  The present invention relates to chirally controlled oligonucleotides, chirally controlled oligonucleotide compositions, and the method of making and using the same. The invention specifically encompasses the identification of the source of certain problems with prior methodologies for preparing chiral oligonucleotides, including problems that prohibit preparation of fully chirally controlled compositions, particularly compositions comprising a plurality of oligonucleotide types. In some embodiments, the present invention provides chirally controlled oligonucleotide compositions. In some embodiments, the present invention provides methods of making chirally controlled oligonucleotides and chirally controlled oligonucleotide compositions.

  本发明涉及手性控制的寡核苷酸、手性控制的寡核苷酸组合物以及其制备和使用方法。本发明特别涵盖了鉴定以前制备手性寡核苷酸方法中某些问题的来源，包括禁止制备完全手性控制的组合物，特别是包含多种寡核苷酸类型的组合物。在某些实施例中，本发明提供了手性控制的寡核苷酸组合物。在某些实施例中，本发明提供了制备手性控制的寡核苷酸和手性控制的寡核苷酸组合物的方法。
• THIOSULFONATE REAGENTS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS
  申请人：Wave Life Sciences Ltd.

  公开号：EP3248982A1

  公开（公告）日：2017-11-29

  Described herein are thiosulfonate reagents of Structure IIa useful for the synthesis of phosphorothiotriesters from H-phosphonates in a stereospecific fashion. wherein, X is alkyl, cycloalkyl, or heteroaryl; R is R1-R2; R1 is selected from -S-alkenylene-, -S-alkylene-, -S-alkylene-aryl-alkylene-, -S-CO-aryl-alkylene-, and -S-CO-alkylene-aryl-alkylene-; and R2 is selected from heterocyclo-alkylene-S-, heterocyclo-alkenylene-S-,aminoalkyl-S-, and (alkyl)4N-alkylene-S-.

  本文描述的是结构 IIa 的硫代磺酸试剂，可用于以立体特异性方式从 H-膦酸盐合成硫代磷酸酯。 其中 X 是烷基、环烷基或杂芳基； R 是 R1-R2； R1 选自-S-亚烷基、-S-亚烷基、-S-亚烷基-芳基-亚烷基、-S-CO-芳基-亚烷基和-S-CO-亚烷基-芳基-亚烷基；以及 R2 选自杂环亚烷基-S-、杂环亚烯基-S-、氨基烷基-S-和（烷基）4N-亚烷基-S-。
• METHODS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS
  申请人：Wave Life Sciences Ltd.

  公开号：EP2734208B1

  公开（公告）日：2017-03-01
• METHOD FOR MAKING CHIRAL OLIGONUCLEOTIDES
  申请人：Wave Life Sciences Ltd.

  公开号：EP2872147B1

  公开（公告）日：2022-12-21
• CHIRAL DESIGN
  申请人：WAVE LIFE SCIENCES LTD.

  公开号：US20170037399A1

  公开（公告）日：2017-02-09

  The present invention relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer.